NXN-188

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
INTRODUCTION Ample evidence that nitric oxide (NO) is a causative molecule in migraine has encouraged research to develop drugs… Expand
Is this relevant?
2013
2013
BACKGROUND NXN-188 is a combined neuronal nitric oxide synthase (nNOS) inhibitor and 5-hydroxytryptamine 1B/1D (5-HT1B/1D… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Background and aims NXN-188 is a combined neuronal nitric oxide synthase (nNOS) inhibitor and 5HT-1B/1D receptor agonist which… Expand
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2013
2013
Hougaard et al. [1] in this issueof the Scandinavian Journal of Pain eportona randomised,doubleblind,placebocontrolledcross-over… Expand
Is this relevant?
Review
2010
Review
2010
BACKGROUND NXN-188 is a dual-action oral therapeutic being developed for the treatment of acute migraine. The mechanism of action… Expand
Is this relevant?